Assessment of Early Pregnancy MAB Completion

University of Washington

Status: Not yet enrolling

Conditions: Abortion Early; Pregnancy

Treatments: Diagnostic Test: Weekly high-sensitivity urine pregnancy tests

Study type: Observational

Funder types: Other

Identifiers

NCT06893484

STUDY00022025

Details and patient eligibility

About

This is a prospective study to evaluate if successful completion of a medication abortion in patients with very early pregnancy can be detected with a urine pregnancy test at 2 weeks instead of 4 weeks. Additionally, the resolution of pregnancy symptoms in these patients will be characterized. Enrolled participants will take take weekly pregnancy tests and complete weekly questionnaires on their pregnancy symptoms for 4 weeks after their medication abortion.

Enrollment: 400 estimated patients

Sex: Female

Volunteers: No Healthy Volunteers

Inclusion criteria

• Pregnant person with early pregnancy ≤42 days
• Eligible and consented to a medication abortion
• Have access to receiving text messages and the internet
• Able to read and understand English

Exclusion criteria

• Privacy or safety concerns about filling out the surveys

Trial design

400 participants in 1 patient group

Participants with Early Pregnancy

Description:

Participants with early pregnancy ≤ 42 days by last menstrual period or ultrasound undergoing a medication abortion will be enrolled.

Treatment:

Diagnostic Test: Weekly high-sensitivity urine pregnancy tests